Perspective Therapeutics, Inc. (CATX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1M 2M 3M Q3 '21: 2.6M Q4 '21: 2.8M Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 0 Q1 '23: 233K Q2 '23: 588K Q3 '23: 276K Q4 '23: 337K Q1 '24: 325K Q2 '24: 526K Q3 '24: 369K Q4 '24: 234K Q1 '25: 342K Q2 '25: 290K Q3 '25: 209K Q4 '25: 43K Q1 '26: 76K Q2 '26: 81K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-600K 0 600K 1.2M 1.8M Q1 '19: 879K Q2 '19: 879K Q3 '19: 1.2M Q4 '19: 1.1M Q1 '20: 1.7M Q2 '20: 1.1M Q3 '20: 1.2M Q4 '20: 1.2M Q1 '21: 1.4M Q2 '21: 1.3M Q3 '21: 1M Q4 '21: 1.2M Q1 '22: 1.4M Q2 '22: 926K Q3 '22: 414K Q4 '22: -414K Q1 '23: 487K Q2 '23: 248K Q3 '23: 738K Q4 '23: -39K Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: -2.3M Q4 '21: -1.6M Q1 '22: -1.4M Q2 '22: -2.1M Q3 '22: -4.2M Q4 '22: -1.4M Q1 '23: -9.8M Q2 '23: -9.8M Q3 '23: -9.8M Q4 '23: -11.7M Q1 '24: -13M Q2 '24: -14.3M Q3 '24: -18.6M Q4 '24: -45M Q1 '25: -21.8M Q2 '25: -24M Q3 '25: -27.9M Q4 '25: -39.8M Q1 '26: -28.3M Q2 '26: -29.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: -2.2M Q4 '21: -1.6M Q1 '22: -1.3M Q2 '22: -2.1M Q3 '22: -4.1M Q4 '22: -3.3M Q1 '23: -371K Q2 '23: -11.1M Q3 '23: -10.4M Q4 '23: -24.7M Q1 '24: -12.3M Q2 '24: -11.7M Q3 '24: -15.1M Q4 '24: -40.2M Q1 '25: -18.2M Q2 '25: -21.5M Q3 '25: -26M Q4 '25: -37.5M Q1 '26: -26.2M Q2 '26: -26.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 700K 1.4M 2.1M Q4 '18: 1.1M Q1 '19: 1M Q2 '19: 1M Q3 '19: 1.1M Q4 '19: 1.1M Q1 '20: 1.2M Q2 '20: 1.2M Q3 '20: 1.1M Q4 '20: 1.2M Q1 '21: 1.2M Q2 '21: 1.4M Q3 '21: 1.5M Q4 '21: 1.6M Q1 '22: 1.5M Q2 '22: 1.6M Q3 '22: 1.3M Q4 '22: 1.4M Q1 '23: 1.6M Q2 '23: 1.8M Q3 '23: 1.4M Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: -2.1M Q4 '21: -1.3M Q1 '22: -1.4M Q2 '22: -2.9M Q3 '22: -1.8M Q4 '22: -4.3M Q1 '23: -9.7M Q2 '23: -8.1M Q3 '23: -10.1M Q4 '23: -9M Q1 '24: 13.8M Q2 '24: -8.9M Q3 '24: 3.4M Q4 '24: -26.6M Q1 '25: -21.6M Q2 '25: -20M Q3 '25: -16.3M Q4 '25: -24.7M Q1 '26: -31.5M Q2 '26: -20.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: -2.1M Q4 '21: -1.4M Q1 '22: -1.4M Q2 '22: -3M Q3 '22: -1.9M Q4 '22: -4.4M Q1 '23: -9.9M Q2 '23: -8.6M Q3 '23: -10.3M Q4 '23: -9.1M Q1 '24: 4.8M Q2 '24: -9.9M Q3 '24: -26.3M Q4 '24: -41.2M Q1 '25: -26.2M Q2 '25: -21M Q3 '25: -18.3M Q4 '25: -29.7M Q1 '26: -38.3M Q2 '26: -34.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q3 '20: 68.9M Q4 '20: 83M Q1 '21: 122.6M Q2 '21: 141.7M Q3 '21: 141.9M Q4 '21: 142M Q1 '22: 142M Q2 '22: 142M Q3 '22: 142.1M Q1 '23: 228.6M Q2 '23: 28M Q3 '23: 28.1M Q1 '24: 49.5M Q2 '24: 66.6M Q3 '24: 70.6M Q1 '25: 72.4M Q2 '25: 74.2M Q3 '25: 74.3M Q1 '26: 103.6M Q2 '26: 120.7M Q4 '20 Q3 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '21: -0.05 Q4 '21: -0.05 Q1 '22: -0.05 Q2 '22: -0.05 Q3 '22: -0.06 Q4 '22: -0.07 Q1 '23: -0.06 Q2 '23: -0.45 Q3 '23: -0.79 Q4 '23: -1.68 Q1 '24: -1.93 Q2 '24: -1.71 Q3 '24: -1.55 Q4 '24: -1.25 Q1 '25: -1.25 Q2 '25: -1.36 Q3 '25: -1.50 Q4 '25: -1.40 Q1 '26: -1.40 Q2 '26: -1.33 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.